Rat Model Market 2027 By Model Type, Service, Therapeutic Area, Technology, End User | The Insight Partners

Rat Model Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Model Type ( Outbred Rats, Inbred Rats, Knockout or Genetically Modified Rats, Hybrid or Congenic Rats, Conditioned or Surgically Modified Rats, Immunodeficient Rats ); Service ( Breeding, Cryopreservation, Quarantine, Rederivation, Model in licensing, Genetic Testing, Other Services ); Therapeutic Area ( Toxicology, Oncology, Immunology and Inflammation, Neurology, Diabetes, Other Therapeutic Areas ); Technology ( CRISPR, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer, Other Technologies ); End User ( Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations (CROs) ),

Report Code: TIPRE00015979 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

There is a need for preclinical animal models such as mice and rats that are used to predict drug effectiveness and toxicity in humans. Due to their genetic similarities to humans as well as their large supply and ease of manipulation, rats are widely used. For instance, by inactivating or silencing an existing gene and replacing it with an artificial piece of DNA, Knockout rats are formed, resulting in the loss of gene activity. This leads to improvements in the phenotypic features of the rat, such as appearance, behavior, and other biochemical characteristics that are similar to human being. The high growth in using rat models can be due to their use to carry out researches on disease such as oncology, obesity, heart disease, diabetes, arthritis, drug abuse, anxiety, and other.

MARKET DYNAMICS

Rat model market is driving due to factors such as advancements in gene editing tools set to augment the demand for rat models, advantages offered by rats over mice, continuous support in the form of investments and grants, increased demand for personalized humanized rat models due to growing consumption of personalized medicines. However, factors such as, regulations & laws formulated for ethical use of animals and availability of alternatives to animal models through advance technologies is expected to hamper the market growth.

MARKET SCOPE

The Rat model market analysis to 2027 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Rat model market with detailed market segmentation by model type, service, therapeutic area, technology and end user. The Rat model market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Rat model market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Rat model market is segmented on the basis of model type, service, therapeutic area, technology and end user. Based on model type, the market is segmented as outbred rats, inbred rats, knockout or genetically modified rats, hybrid or congenic rats, conditioned or surgically modified rats, immunodeficient rats. Based on service, market is segmented as breeding, cryopreservation, quarantine, rederivation, model-in-licensing, genetic testing, other services. Based on therapeutic areas, market can be segmented as toxicology, oncology, immunology and inflammation, neurology, diabetes, other therapeutic areas. Based on technology, market can be segmented as CRISPR, microinjection, embryonic stem cell injection, nuclear transfer, other technologies. Based on end users, market is segmented as pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations (CROs).

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Rat model market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Rat model market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Rat model market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Rat model market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Rat model market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Rat model market are anticipated to have lucrative growth opportunities in the future with the rising demand for Rat model in the global market. Below mentioned is the list of few companies engaged in the Rat model market.

The report also includes the profiles of key players in Rat model market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Charles River Laboratories International,
  •  Envigo
  •  Taconic Biosciences
  •  Horizon Discovery Group
  •  genOway
  •  Laboratory Corporation of America Holdings
  •  Transposagen Biopharmaceuticals
  •  Transviragen
  •  Janvier Labs
  •  Biomere

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Rat Model Market - By Model Type
1.3.2 Rat Model Market - By Service
1.3.3 Rat Model Market - By Therapeutic Area
1.3.4 Rat Model Market - By Technology
1.3.5 Rat Model Market - By End User
1.3.6 Rat Model Market - By Region
1.3.6.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. RAT MODEL MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. RAT MODEL MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. RAT MODEL MARKET - GLOBAL MARKET ANALYSIS
6.1. RAT MODEL - GLOBAL MARKET OVERVIEW
6.2. RAT MODEL - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. RAT MODEL MARKET - REVENUE AND FORECASTS TO 2027 – MODEL TYPE
7.1. OVERVIEW
7.2. MODEL TYPE MARKET FORECASTS AND ANALYSIS
7.3. OUTBRED RATS
7.3.1. Overview
7.3.2. Outbred Rats Market Forecast and Analysis
7.4. INBRED RATS
7.4.1. Overview
7.4.2. Inbred Rats Market Forecast and Analysis
7.5. KNOCKOUT OR GENETICALLY MODIFIED RATS
7.5.1. Overview
7.5.2. Knockout or Genetically Modified Rats Market Forecast and Analysis
7.6. HYBRID OR CONGENIC RATS
7.6.1. Overview
7.6.2. Hybrid or Congenic Rats Market Forecast and Analysis
7.7. CONDITIONED OR SURGICALLY MODIFIED RATS
7.7.1. Overview
7.7.2. Conditioned or Surgically Modified Rats Market Forecast and Analysis
7.8. IMMUNODEFICIENT RATS
7.8.1. Overview
7.8.2. Immunodeficient Rats Market Forecast and Analysis
8. RAT MODEL MARKET - REVENUE AND FORECASTS TO 2027 – SERVICE
8.1. OVERVIEW
8.2. SERVICE MARKET FORECASTS AND ANALYSIS
8.3. BREEDING
8.3.1. Overview
8.3.2. Breeding Market Forecast and Analysis
8.4. CRYOPRESERVATION
8.4.1. Overview
8.4.2. Cryopreservation Market Forecast and Analysis
8.5. QUARANTINE
8.5.1. Overview
8.5.2. Quarantine Market Forecast and Analysis
8.6. REDERIVATION
8.6.1. Overview
8.6.2. Rederivation Market Forecast and Analysis
8.7. MODEL IN LICENSING
8.7.1. Overview
8.7.2. Model in licensing Market Forecast and Analysis
8.8. GENETIC TESTING
8.8.1. Overview
8.8.2. Genetic Testing Market Forecast and Analysis
8.9. OTHER SERVICES
8.9.1. Overview
8.9.2. Other Services Market Forecast and Analysis
9. RAT MODEL MARKET - REVENUE AND FORECASTS TO 2027 – THERAPEUTIC AREA
9.1. OVERVIEW
9.2. THERAPEUTIC AREA MARKET FORECASTS AND ANALYSIS
9.3. TOXICOLOGY
9.3.1. Overview
9.3.2. Toxicology Market Forecast and Analysis
9.4. ONCOLOGY
9.4.1. Overview
9.4.2. Oncology Market Forecast and Analysis
9.5. IMMUNOLOGY AND INFLAMMATION
9.5.1. Overview
9.5.2. Immunology and Inflammation Market Forecast and Analysis
9.6. NEUROLOGY
9.6.1. Overview
9.6.2. Neurology Market Forecast and Analysis
9.7. DIABETES
9.7.1. Overview
9.7.2. Diabetes Market Forecast and Analysis
9.8. OTHER THERAPEUTIC AREAS
9.8.1. Overview
9.8.2. Other Therapeutic Areas Market Forecast and Analysis
10. RAT MODEL MARKET - REVENUE AND FORECASTS TO 2027 – TECHNOLOGY
10.1. OVERVIEW
10.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
10.3. CRISPR
10.3.1. Overview
10.3.2. CRISPR Market Forecast and Analysis
10.4. MICROINJECTION
10.4.1. Overview
10.4.2. Microinjection Market Forecast and Analysis
10.5. EMBRYONIC STEM CELL INJECTION
10.5.1. Overview
10.5.2. Embryonic Stem Cell Injection Market Forecast and Analysis
10.6. NUCLEAR TRANSFER
10.6.1. Overview
10.6.2. Nuclear Transfer Market Forecast and Analysis
10.7. OTHER TECHNOLOGIES
10.7.1. Overview
10.7.2. Other Technologies Market Forecast and Analysis
11. RAT MODEL MARKET - REVENUE AND FORECASTS TO 2027 – END USER
11.1. OVERVIEW
11.2. END USER MARKET FORECASTS AND ANALYSIS
11.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
11.3.1. Overview
11.3.2. Pharmaceutical and Biotechnology Companies Market Forecast and Analysis
11.4. ACADEMIC AND RESEARCH INSTITUTES
11.4.1. Overview
11.4.2. Academic and Research Institutes Market Forecast and Analysis
11.5. CONTRACT RESEARCH ORGANIZATIONS (CROS)
11.5.1. Overview
11.5.2. Contract Research Organizations (CROs) Market Forecast and Analysis
12. RAT MODEL MARKET REVENUE AND FORECASTS TO 2027 – GEOGRAPHICAL ANALYSIS
12.1. NORTH AMERICA
12.1.1 North America Rat Model Market Overview
12.1.2 North America Rat Model Market Forecasts and Analysis
12.1.3 North America Rat Model Market Forecasts and Analysis - By Model Type
12.1.4 North America Rat Model Market Forecasts and Analysis - By Service
12.1.5 North America Rat Model Market Forecasts and Analysis - By Therapeutic Area
12.1.6 North America Rat Model Market Forecasts and Analysis - By Technology
12.1.7 North America Rat Model Market Forecasts and Analysis - By End User
12.1.8 North America Rat Model Market Forecasts and Analysis - By Countries
12.1.8.1 United States Rat Model Market
12.1.8.1.1 United States Rat Model Market by Model Type
12.1.8.1.2 United States Rat Model Market by Service
12.1.8.1.3 United States Rat Model Market by Therapeutic Area
12.1.8.1.4 United States Rat Model Market by Technology
12.1.8.1.5 United States Rat Model Market by End User
12.1.8.2 Canada Rat Model Market
12.1.8.2.1 Canada Rat Model Market by Model Type
12.1.8.2.2 Canada Rat Model Market by Service
12.1.8.2.3 Canada Rat Model Market by Therapeutic Area
12.1.8.2.4 Canada Rat Model Market by Technology
12.1.8.2.5 Canada Rat Model Market by End User
12.1.8.3 Mexico Rat Model Market
12.1.8.3.1 Mexico Rat Model Market by Model Type
12.1.8.3.2 Mexico Rat Model Market by Service
12.1.8.3.3 Mexico Rat Model Market by Therapeutic Area
12.1.8.3.4 Mexico Rat Model Market by Technology
12.1.8.3.5 Mexico Rat Model Market by End User
12.2. EUROPE
12.2.1 Europe Rat Model Market Overview
12.2.2 Europe Rat Model Market Forecasts and Analysis
12.2.3 Europe Rat Model Market Forecasts and Analysis - By Model Type
12.2.4 Europe Rat Model Market Forecasts and Analysis - By Service
12.2.5 Europe Rat Model Market Forecasts and Analysis - By Therapeutic Area
12.2.6 Europe Rat Model Market Forecasts and Analysis - By Technology
12.2.7 Europe Rat Model Market Forecasts and Analysis - By End User
12.2.8 Europe Rat Model Market Forecasts and Analysis - By Countries
12.2.8.1 Germany Rat Model Market
12.2.8.1.1 Germany Rat Model Market by Model Type
12.2.8.1.2 Germany Rat Model Market by Service
12.2.8.1.3 Germany Rat Model Market by Therapeutic Area
12.2.8.1.4 Germany Rat Model Market by Technology
12.2.8.1.5 Germany Rat Model Market by End User
12.2.8.2 France Rat Model Market
12.2.8.2.1 France Rat Model Market by Model Type
12.2.8.2.2 France Rat Model Market by Service
12.2.8.2.3 France Rat Model Market by Therapeutic Area
12.2.8.2.4 France Rat Model Market by Technology
12.2.8.2.5 France Rat Model Market by End User
12.2.8.3 Italy Rat Model Market
12.2.8.3.1 Italy Rat Model Market by Model Type
12.2.8.3.2 Italy Rat Model Market by Service
12.2.8.3.3 Italy Rat Model Market by Therapeutic Area
12.2.8.3.4 Italy Rat Model Market by Technology
12.2.8.3.5 Italy Rat Model Market by End User
12.2.8.4 Spain Rat Model Market
12.2.8.4.1 Spain Rat Model Market by Model Type
12.2.8.4.2 Spain Rat Model Market by Service
12.2.8.4.3 Spain Rat Model Market by Therapeutic Area
12.2.8.4.4 Spain Rat Model Market by Technology
12.2.8.4.5 Spain Rat Model Market by End User
12.2.8.5 United Kingdom Rat Model Market
12.2.8.5.1 United Kingdom Rat Model Market by Model Type
12.2.8.5.2 United Kingdom Rat Model Market by Service
12.2.8.5.3 United Kingdom Rat Model Market by Therapeutic Area
12.2.8.5.4 United Kingdom Rat Model Market by Technology
12.2.8.5.5 United Kingdom Rat Model Market by End User
12.2.8.6 Rest of Europe Rat Model Market
12.2.8.6.1 Rest of Europe Rat Model Market by Model Type
12.2.8.6.2 Rest of Europe Rat Model Market by Service
12.2.8.6.3 Rest of Europe Rat Model Market by Therapeutic Area
12.2.8.6.4 Rest of Europe Rat Model Market by Technology
12.2.8.6.5 Rest of Europe Rat Model Market by End User
12.3. ASIA-PACIFIC
12.3.1 Asia-Pacific Rat Model Market Overview
12.3.2 Asia-Pacific Rat Model Market Forecasts and Analysis
12.3.3 Asia-Pacific Rat Model Market Forecasts and Analysis - By Model Type
12.3.4 Asia-Pacific Rat Model Market Forecasts and Analysis - By Service
12.3.5 Asia-Pacific Rat Model Market Forecasts and Analysis - By Therapeutic Area
12.3.6 Asia-Pacific Rat Model Market Forecasts and Analysis - By Technology
12.3.7 Asia-Pacific Rat Model Market Forecasts and Analysis - By End User
12.3.8 Asia-Pacific Rat Model Market Forecasts and Analysis - By Countries
12.3.8.1 Australia Rat Model Market
12.3.8.1.1 Australia Rat Model Market by Model Type
12.3.8.1.2 Australia Rat Model Market by Service
12.3.8.1.3 Australia Rat Model Market by Therapeutic Area
12.3.8.1.4 Australia Rat Model Market by Technology
12.3.8.1.5 Australia Rat Model Market by End User
12.3.8.2 China Rat Model Market
12.3.8.2.1 China Rat Model Market by Model Type
12.3.8.2.2 China Rat Model Market by Service
12.3.8.2.3 China Rat Model Market by Therapeutic Area
12.3.8.2.4 China Rat Model Market by Technology
12.3.8.2.5 China Rat Model Market by End User
12.3.8.3 India Rat Model Market
12.3.8.3.1 India Rat Model Market by Model Type
12.3.8.3.2 India Rat Model Market by Service
12.3.8.3.3 India Rat Model Market by Therapeutic Area
12.3.8.3.4 India Rat Model Market by Technology
12.3.8.3.5 India Rat Model Market by End User
12.3.8.4 Japan Rat Model Market
12.3.8.4.1 Japan Rat Model Market by Model Type
12.3.8.4.2 Japan Rat Model Market by Service
12.3.8.4.3 Japan Rat Model Market by Therapeutic Area
12.3.8.4.4 Japan Rat Model Market by Technology
12.3.8.4.5 Japan Rat Model Market by End User
12.3.8.5 South Korea Rat Model Market
12.3.8.5.1 South Korea Rat Model Market by Model Type
12.3.8.5.2 South Korea Rat Model Market by Service
12.3.8.5.3 South Korea Rat Model Market by Therapeutic Area
12.3.8.5.4 South Korea Rat Model Market by Technology
12.3.8.5.5 South Korea Rat Model Market by End User
12.3.8.6 Rest of Asia-Pacific Rat Model Market
12.3.8.6.1 Rest of Asia-Pacific Rat Model Market by Model Type
12.3.8.6.2 Rest of Asia-Pacific Rat Model Market by Service
12.3.8.6.3 Rest of Asia-Pacific Rat Model Market by Therapeutic Area
12.3.8.6.4 Rest of Asia-Pacific Rat Model Market by Technology
12.3.8.6.5 Rest of Asia-Pacific Rat Model Market by End User
12.4. MIDDLE EAST AND AFRICA
12.4.1 Middle East and Africa Rat Model Market Overview
12.4.2 Middle East and Africa Rat Model Market Forecasts and Analysis
12.4.3 Middle East and Africa Rat Model Market Forecasts and Analysis - By Model Type
12.4.4 Middle East and Africa Rat Model Market Forecasts and Analysis - By Service
12.4.5 Middle East and Africa Rat Model Market Forecasts and Analysis - By Therapeutic Area
12.4.6 Middle East and Africa Rat Model Market Forecasts and Analysis - By Technology
12.4.7 Middle East and Africa Rat Model Market Forecasts and Analysis - By End User
12.4.8 Middle East and Africa Rat Model Market Forecasts and Analysis - By Countries
12.4.8.1 South Africa Rat Model Market
12.4.8.1.1 South Africa Rat Model Market by Model Type
12.4.8.1.2 South Africa Rat Model Market by Service
12.4.8.1.3 South Africa Rat Model Market by Therapeutic Area
12.4.8.1.4 South Africa Rat Model Market by Technology
12.4.8.1.5 South Africa Rat Model Market by End User
12.4.8.2 Saudi Arabia Rat Model Market
12.4.8.2.1 Saudi Arabia Rat Model Market by Model Type
12.4.8.2.2 Saudi Arabia Rat Model Market by Service
12.4.8.2.3 Saudi Arabia Rat Model Market by Therapeutic Area
12.4.8.2.4 Saudi Arabia Rat Model Market by Technology
12.4.8.2.5 Saudi Arabia Rat Model Market by End User
12.4.8.3 U.A.E Rat Model Market
12.4.8.3.1 U.A.E Rat Model Market by Model Type
12.4.8.3.2 U.A.E Rat Model Market by Service
12.4.8.3.3 U.A.E Rat Model Market by Therapeutic Area
12.4.8.3.4 U.A.E Rat Model Market by Technology
12.4.8.3.5 U.A.E Rat Model Market by End User
12.4.8.4 Rest of Middle East and Africa Rat Model Market
12.4.8.4.1 Rest of Middle East and Africa Rat Model Market by Model Type
12.4.8.4.2 Rest of Middle East and Africa Rat Model Market by Service
12.4.8.4.3 Rest of Middle East and Africa Rat Model Market by Therapeutic Area
12.4.8.4.4 Rest of Middle East and Africa Rat Model Market by Technology
12.4.8.4.5 Rest of Middle East and Africa Rat Model Market by End User
12.5. SOUTH AND CENTRAL AMERICA
12.5.1 South and Central America Rat Model Market Overview
12.5.2 South and Central America Rat Model Market Forecasts and Analysis
12.5.3 South and Central America Rat Model Market Forecasts and Analysis - By Model Type
12.5.4 South and Central America Rat Model Market Forecasts and Analysis - By Service
12.5.5 South and Central America Rat Model Market Forecasts and Analysis - By Therapeutic Area
12.5.6 South and Central America Rat Model Market Forecasts and Analysis - By Technology
12.5.7 South and Central America Rat Model Market Forecasts and Analysis - By End User
12.5.8 South and Central America Rat Model Market Forecasts and Analysis - By Countries
12.5.8.1 Brazil Rat Model Market
12.5.8.1.1 Brazil Rat Model Market by Model Type
12.5.8.1.2 Brazil Rat Model Market by Service
12.5.8.1.3 Brazil Rat Model Market by Therapeutic Area
12.5.8.1.4 Brazil Rat Model Market by Technology
12.5.8.1.5 Brazil Rat Model Market by End User
12.5.8.2 Argentina Rat Model Market
12.5.8.2.1 Argentina Rat Model Market by Model Type
12.5.8.2.2 Argentina Rat Model Market by Service
12.5.8.2.3 Argentina Rat Model Market by Therapeutic Area
12.5.8.2.4 Argentina Rat Model Market by Technology
12.5.8.2.5 Argentina Rat Model Market by End User
12.5.8.3 Rest of South and Central America Rat Model Market
12.5.8.3.1 Rest of South and Central America Rat Model Market by Model Type
12.5.8.3.2 Rest of South and Central America Rat Model Market by Service
12.5.8.3.3 Rest of South and Central America Rat Model Market by Therapeutic Area
12.5.8.3.4 Rest of South and Central America Rat Model Market by Technology
12.5.8.3.5 Rest of South and Central America Rat Model Market by End User
13. IMPACT OF COVID-19 PANDEMIC ON GLOBAL RAT MODEL MARKET
13.1 North America
13.2 Europe
13.3 Asia-Pacific
13.4 Rest of the World
14. INDUSTRY LANDSCAPE
14.1. MERGERS AND ACQUISITIONS
14.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
14.3. NEW PRODUCT LAUNCHES
14.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
15. RAT MODEL MARKET, KEY COMPANY PROFILES
15.1. CHARLES RIVER LABORATORIES INTERNATIONAL,
15.1.1. Key Facts
15.1.2. Business Description
15.1.3. Products and Services
15.1.4. Financial Overview
15.1.5. SWOT Analysis
15.1.6. Key Developments
15.2. ENVIGO
15.2.1. Key Facts
15.2.2. Business Description
15.2.3. Products and Services
15.2.4. Financial Overview
15.2.5. SWOT Analysis
15.2.6. Key Developments
15.3. TACONIC BIOSCIENCES
15.3.1. Key Facts
15.3.2. Business Description
15.3.3. Products and Services
15.3.4. Financial Overview
15.3.5. SWOT Analysis
15.3.6. Key Developments
15.4. HORIZON DISCOVERY GROUP
15.4.1. Key Facts
15.4.2. Business Description
15.4.3. Products and Services
15.4.4. Financial Overview
15.4.5. SWOT Analysis
15.4.6. Key Developments
15.5. GENOWAY
15.5.1. Key Facts
15.5.2. Business Description
15.5.3. Products and Services
15.5.4. Financial Overview
15.5.5. SWOT Analysis
15.5.6. Key Developments
15.6. LABORATORY CORPORATION OF AMERICA HOLDINGS
15.6.1. Key Facts
15.6.2. Business Description
15.6.3. Products and Services
15.6.4. Financial Overview
15.6.5. SWOT Analysis
15.6.6. Key Developments
15.7. TRANSPOSAGEN BIOPHARMACEUTICALS
15.7.1. Key Facts
15.7.2. Business Description
15.7.3. Products and Services
15.7.4. Financial Overview
15.7.5. SWOT Analysis
15.7.6. Key Developments
15.8. TRANSVIRAGEN
15.8.1. Key Facts
15.8.2. Business Description
15.8.3. Products and Services
15.8.4. Financial Overview
15.8.5. SWOT Analysis
15.8.6. Key Developments
15.9. JANVIER LABS
15.9.1. Key Facts
15.9.2. Business Description
15.9.3. Products and Services
15.9.4. Financial Overview
15.9.5. SWOT Analysis
15.9.6. Key Developments
15.10. BIOMERE
15.10.1. Key Facts
15.10.2. Business Description
15.10.3. Products and Services
15.10.4. Financial Overview
15.10.5. SWOT Analysis
15.10.6. Key Developments
16. APPENDIX
16.1. ABOUT THE INSIGHT PARTNERS
16.2. GLOSSARY OF TERMS
The List of Companies

1. Charles River Laboratories International,
2. Envigo
3. Taconic Biosciences
4. Horizon Discovery Group
5. genOway
6. Laboratory Corporation of America Holdings
7. Transposagen Biopharmaceuticals
8. Transviragen
9. Janvier Labs
10. Biomere
TIPRE00015979
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking